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January 28, 2010
Dear Premier Charest:
As scientists from twenty-eight
countries, dedicated to protecting
public health, we appeal to you to
respect the overwhelmingly consis-
tent body of scientific evidence and
the considered judgment of the
World Health Organization
(WHO) that all forms of asbestos
have been shown to be deadly and
that safe use of any form of asbestos
has proven impossible anywhere in
the world.
We appeal to you to act hon-
ourably and to listen to Quebec’s
own public health experts,1 promi-
nent health experts across Canada,2
as well as the Canadian Medical
Association,3 the Quebec Cancer
Society,4 and the World Health
Organization (WHO),5 who have
all called for the use and export of
asbestos to end.
We wish to draw your attention
to the following troubling points,
which suggest that your govern-
ment is practising a double stan-
dard, thus bringing dishonor on
Quebec’s international reputation.
1) Quebec itself is experiencing an 
epidemic of asbestos-related disease.
In Quebec itself, exposure to
asbestos is the single biggest cause of
worker death. Figures for 2009 from
the Quebec Workers’ Compensation
2) Quebec itself does not use chrysotile
asbestos.
Quebec itself uses virtually none of
the asbestos it mines, in spite of
major infrastructure projects cur-
rently underway. The government’s
2002 policy of increased use of chry-
sotile asbestos in Quebec12 is a policy
that has not been implemented, as
the people of Quebec, in order to
protect their own and their chil-
dren’s health, do not want asbestos
in their schools, hospitals, or homes.
Instead, virtually all Quebec’s
asbestos is exported to developing
countries, where protections are few
and awareness of the hazards of
asbestos almost non-existent.
3) Quebec is removing chrysotile
asbestos from its buildings.
Your government is spending mil-
lions of dollars to remove chrysotile
asbestos and other forms of
asbestos from Quebec’s schools,
hospitals, and buildings, while at
the same time exporting it to devel-
oping countries and telling them it
is safe. This seems to represent a
high level of hypocrisy.
Furthermore, Quebec has the
financial resources, trained experts
and specialized equipment to
remove dangerous deteriorated
chrysotile asbestos from its build-
ings; developing countries do not.
4) Quebec itself has failed to achieve
“safe use” of chrysotile asbestos.
Your government’s own expert
Public Health Institute (INSPQ)
has published 15 reports,13 all of
them documenting that it has
proven impossible to handle
Board show 60% of occupational
deaths were caused by asbestos.6
Other statistics confirm that
Quebec is experiencing an appalling
epidemic of asbestos-related disease.
Official data shows 134 new cases of
mesothelioma reported in Quebec
in 2004,7 and Quebec’s National
Public Health Institute (INSPQ)
reports 211 cases of asbestosis in
2004.8 It is well recognized that for
every case of mesothelioma, asbestos
causes two to three times as many
cases of lung cancer.9
This gives a total of 612 new cases
of asbestos-related disease in Quebec in
2004 (134 recorded cases of
mesothelioma, 211 recorded cases
of asbestosis, and a conservative esti-
mate of 268 cases of lung cancer). 
From 1992 to 2006, the annual
number of Quebec cases of meso-
thelioma has risen from 92 to 142.7
We note that in 2007, facing
high numbers of cases of asbestosis,
your government’s health authori-
ties set up a special program, using
a mobile x-ray clinic to travel
around the province and give chest
x-rays to construction workers, in
an endeavour to identify and aid
workers with signs of asbestosis.10
This is a public health calamity
and one that would not have hap-
pened if the industry’s denial of
the hazards of asbestos had not
been believed. And as leading
expert Professor. Paul Demers of
the University of British Columbia
states, “Much of the burden of
asbestos-related disease remains
unrecognized.”11
We call on you not to export this
same public health tragedy to
developing countries, where surely
there is more than enough injustice
and suffering already.
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chrysotile asbestos safely in Quebec
itself. The INSPQ states that “safe
use” of chrysotile asbestos is likely
impossible, particularly for con-
struction workers, and it therefore
opposes your government’s policy
of increased use of chrysotile
asbestos.14
A research project by several of
your government’s top health agen-
cies found that, in the miniscule
number of workplaces in Quebec
still using chrysotile asbestos today,
there was a 100% failure rate to
practice “safe use” standards. The
report recommended that equip-
ment containing asbestos be
replaced by safer, non-asbestos con-
taining equipment.15
When Quebec itself is unable to
achieve “safe use” of chrysotile
asbestos, how can anyone pretend
that chrysotile asbestos can be han-
dled safely in developing countries,
which lack the resources, regula-
tory controls, and technological
advantages Quebec enjoys?
5) There is no safe exposure level for
chrysotile asbestos.
According to a spokesperson for
Quebec’s Occupational Health and
Safety Commission (CSST), the
government of Quebec has
adopted a "zero tolerance" policy
for exposure to asbestos.16 We
applaud your government for seek-
ing thus to protect Quebec workers
from asbestos harm. We call on you
to show equal concern for the lives
of workers in the developing world. 
We are deeply troubled that,
instead, your government is
endorsing the position of the
Chrysotile Institute, telling devel-
oping countries that exposure of 1
fibre of chrysotile asbestos per
cubic centimetre of air (1 f/cc) is
perfectly safe for them.17 While this
is indeed the position of the
asbestos industry, it is not the posi-
tion of independent experts. The
WHO, the Canadian Cancer Soci-
ety, the US Surgeon General, and
the fifty countries who have banned
chrysotile asbestos state that there
is no safe exposure level for
chrysotile asbestos. Exposure levels
of 1 f/cc will cause unnecessary dis-
ease and death for those exposed. 
We find it shocking that the expo-
sure level you endorse for people
overseas is ten times higher than the
level permitted by all of the other
provinces in Canada, by the US, by
the European Union, and by other
Western industrialized countries. It
is one hundred times higher than
the exposure level permitted in sev-
eral countries, such as Germany,
Switzerland, and the Netherlands. 
We note that samples taken
during a five-year period from 1995
to 2000 for asbestos workers at
Thetford Mines showed that the 1
f/cc standard was exceeded in
more than 10% of the samples, with
workers being exposed to levels
from 1.02 f/cc to 5.15 f/cc.18
A recent CBC documentary
Canada’s Ugly Secret19 showed work-
ers in India handling Quebec’s
asbestos who are exposed to far
higher levels than 1 f/cc.
6) Industry misinformation is funded
by your government.
Chrysotile asbestos represents
100% of the world asbestos trade. It
represents 95% of all the asbestos
ever used. The chrysotile asbestos
industry in Quebec, Kazakhstan,
Zimbabwe, and Russia all claim that
chrysotile asbestos can and is being
safely used. 
The information put out by the
asbestos industry is, however, com-
pletely discredited. Health experts
in Quebec and around the world
have documented and condemned
the misleading and untruthful infor-
mation the industry disseminates.20
We draw to your attention that a
favorite expert of the Chrysotile
Institute (a registered lobby group
for the Quebec asbestos industry
funded by your government21 and
on whose board a representative of
your government sits) is Christo-
pher Booker,22 who has no appar-
ent scientific credentials and who
considers climate change, harm
from chrysotile asbestos, harm
from tobacco smoke, and harm
from lead in gasoline to all be hys-
terical hoaxes.23
Recently, the pro-chrysotile
movement and Dr. Jacques Dunni-
gan (a long-time employee and
spokesperson for the Chrysotile
Institute) falsely presented to the
Quebec public a US Department of
of Health and Human Services
(DHHS) Priority List of Hazardous
Substances based on the Compre-
hensive Environmental Response,
Compensation, and Liability Act
(CERCLA, also known as “Super-
fund”)24 as evidence proving that
chrysotile asbestos is a low threat to
health, noting that chrysotile
asbestos is #119 on the list.
What they did not disclose, how-
ever, is that the list relates only to
clean-up of wastes at Superfund
toxic sites in the US, where
chrysotile asbestos is not signifi-
cantly present. If Dr. Dunnigan and
the pro-chrysotile movement had
bothered to read the list, they would
have seen that amosite asbestos,
which they themselves recognize as
an extremely hazardous substance,
is listed at #131, that is, less haz-
ardous than chrysotile asbestos, and
plutonium, an extremely deadly
substance, is listed at #121.
In fact, the US DHHS website
specifically provides a warning that
the list is NOT a list of most toxic
substances and should NOT be
treated as such.25
We find it incomprehensible and
extremely disappointing to learn
that Radio Canada’s news program
Le Téléjournal presented the list to
its viewers as authentic evidence of
the low risk of chrysotile asbestos,
when the most elementary journal-
istic standards, such as reading the
list or the document containing the
list, would immediately reveal this
purported evidence to be a hoax.26
It is hard to believe that Dr. Dunni-
gan and Radio-Canada could
demonstrate such extreme igno-
rance and irresponsibility, but the
alternative explanation of deliberate
deception is even more disturbing.
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We note that in an earlier pro-
gram on chrysotile asbestos, Le
Téléjournal interviewed five
people, every one of whom was a
proponent of, and had a connec-
tion to, the asbestos industry. In
response to complaints, the Radio-
Canada ombudsman ruled that Le
Téléjournal’s program was biased
and violated the journalism stan-
dards of Radio-Canada.
7) Efforts by the asbestos industry to
intimidate and silence scientists.
We note with dismay that the
asbestos industry, as well as Laurent
Lessard, a minister in your govern-
ment who represents the asbestos
mining area, have vilified and
threatened your government’s
National Public Health Institute
(INSPQ), thus creating a climate of
intimidation to inhibit these health
professionals from practicing inde-
pendent science without fear or
favor. Bernard Coulombe, who is a
director of the Chrysotile Institute
and president of the Jeffrey
asbestos mine, has called the
INSPQ “a little bunch of Talibans”27
and Minister Lessard has spoken of
“repercussions” on the INSPQ.28
We note also that the asbestos
industry’s supporters have informed
your government that they are dis-
pleased that the INSPQ’s research
reveals health problems caused by
asbestos, strongly implying that they
would like you to silence the incon-
venient truths about asbestos that
the INSPQ documents.29
We are extremely disturbed that
the asbestos industry in India—
Quebec’s number one asbestos cus-
tomer, with whom the Quebec indus-
try works closely—has recently sent
letters to a number of scientists in
India saying that legal action will be
taken against them if they do not
retract their statements and pub-
lished articles concerning the threat
to health posed by chrysotile asbestos.
The asbestos industry, including
the Quebec Chrysotile Institute
that your government funds, has a
long history of seeking to silence,
Under Canadian law, chrysotile
asbestos is classified as a hazardous
substance, but the Quebec govern-
ment has successfully lobbied to
prevent it being recognized as such
under international environmental
law, thus creating a double stan-
dard of protection as if some lives
were less deserving of protection
than others.
We note that at the December
2009 Copenhagen Conference you
called on Canada to show stronger
commitment to implementing the
UN Climate Change Convention.
We ask you to show similar commit-
ment to implementing the UN Rot-
terdam Convention.
OUR APPEAL TO YOU
In light of the above disturbing
facts, we appeal to you, as you are
about to leave on a trade mission to
India, to show the integrity and
honor that the world expects of
Quebec. We ask that you listen to
the overwhelming evidence put for-
ward by independent health
experts, including your own
Quebec health experts, and not
succumb to the political lobbying
of the asbestos industry.
We call on you, as well as the
leaders of the other Quebec politi-
cal parties, to end Quebec’s export
of asbestos, to stop funding the
Chrysotile Institute, to support the
listing of chrysotile asbestos under
the UN Rotterdam Convention, to
assist the last 340 asbestos miners
and their community with eco-
nomic diversification, and to
address the asbestos disease epi-
demic in Quebec.
We thank you for giving our
request your consideration and
look forward with hope and antici-
pation to receiving your response.
Sincerely,
TIM K. TAKARO, MD, MPH, MS
Associate Professor, Acting Associate
Dean for Research
Faculty of Health Sciences
Simon Fraser University
British Columbia, Canada 
by lawsuits or other means, those
who oppose use of asbestos. In
November 2007, the Quebec
Chrysotile Institute filed a lawsuit
in France against the National Asso-
ciation of Victims of Asbestos
(ANDEVA), causing them financial
and human costs, only to withdraw
the case on the court-house steps in
March 2009 after ANDEVA refused
to be intimidated.
These actions by the asbestos
industry to intimidate and silence
scientists are a threat to scientific
and academic freedom of speech
by vested interests and we call on
you, on the eve of your trade mis-
sion to India, to categorically con-
demn such actions against scientists
and to give your unequivocal sup-
port to your government’s own
health scientists.
8) Sabotage of a United Nations 
environmental convention.
We note that your government and
the asbestos industry have success-
fully lobbied the Canadian govern-
ment to block the listing of
chrysotile asbestos as a hazardous
substance under a United Nations
(UN). environmental convention
(the Rotterdam Convention), thus
preventing the recommendation of
the Convention’s expert scientific
body from being implemented, and
thus also jeopardizing the mandate
of the Convention.
The Rotterdam Convention was
created specifically to protect
people in developing countries and
countries in economic transition
from being harmed by hazardous
substances. It provides the basic
human right of prior informed
consent, requiring that countries
be informed that a substance they
may import is hazardous.
It is extremely troubling to see
Quebec instigate sabotage of a UN
environmental convention and thus
deny a basic human right that is
taken for granted in Quebec itself.
This obstruction helps the indus-
try’s sales. But it brings Quebec into
international disrepute.
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